Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Disease Specific Ontology of Adverse Events: Ontology extension and adaptation for Chronic Kidney Disease.

Kang Y, Fink JC, Doerfler R, Zhou L.

Comput Biol Med. 2018 Oct 1;101:210-217. doi: 10.1016/j.compbiomed.2018.08.024. Epub 2018 Aug 28.

PMID:
30195820
2.

Medication Safety Principles and Practice in CKD.

Whittaker CF, Miklich MA, Patel RS, Fink JC.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1738-1746. doi: 10.2215/CJN.00580118. Epub 2018 Jun 18.

PMID:
29915131
3.

Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.

Bundy JD, Bazzano LA, Xie D, Cohan J, Dolata J, Fink JC, Hsu CY, Jamerson K, Lash J, Makos G, Steigerwalt S, Wang X, Mills KT, Chen J, He J; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):993-1001. doi: 10.2215/CJN.11121017. Epub 2018 Jun 7.

PMID:
29880471
4.

The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System.

Spanakis EK, Levitt DL, Siddiqui T, Singh LG, Pinault L, Sorkin J, Umpierrez GE, Fink JC.

J Diabetes Sci Technol. 2018 Jan;12(1):20-25. doi: 10.1177/1932296817748964. Epub 2017 Dec 13.

PMID:
29237288
5.

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.

Weir MR, Pergola PE, Agarwal R, Fink JC, Kopyt NP, Singh AK, Kumar J, Schmitt S, Schaffar G, Rudy A, McKay JP, Kanceva R.

Am J Nephrol. 2017;46(5):364-370. doi: 10.1159/000481736. Epub 2017 Oct 30.

PMID:
29084409
6.

Deprescribing in CKD: The Proof Is in the Process.

Whittaker CF, Fink JC.

Am J Kidney Dis. 2017 Nov;70(5):596-598. doi: 10.1053/j.ajkd.2017.05.025. No abstract available.

PMID:
29055352
7.

Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.

Zhan M, St Peter WL, Doerfler RM, Woods CM, Blumenthal JB, Diamantidis CJ, Hsu CY, Lash JP, Lustigova E, Mahone EB, Ojo AO, Slaven A, Strauss L, Taliercio JJ, Winkelmayer WC, Xie D, Fink JC; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1778-1786. doi: 10.2215/CJN.12311216. Epub 2017 Aug 15.

8.

Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC; for CRIC Study Investigators.

Clin J Am Soc Nephrol. 2017 Aug 9;12(9). pii: CJN.12991216. doi: 10.2215/CJN.12991216. Print 2017 Sep 7.

9.

Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial.

Rajagopalan S, Alaiti MA, Broadwater K, Goud A, Gaztanaga J, Connelly K, Fares A, Shirazian S, Kreatsoulas C, Farkouh M, Dobre M, Fink JC, Weir MR.

Clin Cardiol. 2017 Sep;40(9):633-640. doi: 10.1002/clc.22718. Epub 2017 May 26.

10.

Ensuring Patient Safety During the Transition to ESRD.

Wagner LA, Fink JC.

Semin Nephrol. 2017 Mar;37(2):194-208. doi: 10.1016/j.semnephrol.2016.12.009. Review.

PMID:
28410653
11.

Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD.

Weiner S, Fink JC.

Adv Chronic Kidney Dis. 2017 Jan;24(1):31-38. doi: 10.1053/j.ackd.2016.12.004. Review.

12.

Are Ambulatory Care-Sensitive Conditions the Fulcrum of Hospitalizations for CKD Patients?

Fink JC.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1927-1928. Epub 2016 Oct 6. No abstract available.

13.

Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.

Davis-Ajami ML, Fink JC, Wu J.

J Manag Care Spec Pharm. 2016 Aug;22(8):959-68. doi: 10.18553/jmcp.2016.22.8.959.

14.

Patient-Reported Safety Events in Chronic Kidney Disease Recorded With an Interactive Voice-Inquiry Dial-Response System: Monthly Report Analysis.

Fink JC, Doerfler RM, Yoffe MR, Diamantidis CJ, Blumenthal JB, Siddiqui T, Gardner JF, Snitker S, Zhan M.

J Med Internet Res. 2016 May 26;18(5):e125. doi: 10.2196/jmir.5203.

15.

Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study).

Grunwald JE, Pistilli M, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker-Ostroff C, Mohler E, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D; CRIC Study Investigators.

Am J Cardiol. 2015 Nov 15;116(10):1527-33. doi: 10.1016/j.amjcard.2015.08.015. Epub 2015 Aug 31.

16.

The Effect of Contact Precautions on Frequency of Hospital Adverse Events.

Croft LD, Liquori M, Ladd J, Day H, Pineles L, Lamos E, Arnold R, Mehrotra P, Fink JC, Langenberg P, Simoni-Wastila L, Perencevich E, Harris AD, Morgan DJ.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1268-74. doi: 10.1017/ice.2015.192. Epub 2015 Aug 17.

17.

Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings.

Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI; Chronic Renal Insufficiency Cohort Study Investigators.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2073-83. doi: 10.2215/CJN.04260415. Epub 2015 Aug 11. Review.

18.

Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD.

Diamantidis CJ, Ginsberg JS, Yoffe M, Lucas L, Prakash D, Aggarwal S, Fink W, Becker S, Fink JC.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1364-70. doi: 10.2215/CJN.12591214. Epub 2015 Jul 28.

19.

Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease.

Ricardo AC, Roy JA, Tao K, Alper A, Chen J, Drawz PE, Fink JC, Hsu CY, Kusek JW, Ojo A, Schreiber M, Fischer MJ; CRIC Study Investigators.

J Gen Intern Med. 2016 Jan;31(1):22-9. doi: 10.1007/s11606-015-3452-x. Epub 2015 Jul 3.

20.

Patient safety issues in CKD: core curriculum 2015.

Wagner LA, Tata AL, Fink JC.

Am J Kidney Dis. 2015 Jul;66(1):159-69. doi: 10.1053/j.ajkd.2015.02.343. Epub 2015 May 16. Review. No abstract available.

21.

Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.

Hsu KL, Fink JC, Ginsberg JS, Yoffe M, Zhan M, Fink W, Woods CM, Diamantidis CJ.

Am J Kidney Dis. 2015 Oct;66(4):621-9. doi: 10.1053/j.ajkd.2015.03.026. Epub 2015 May 13.

22.

Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.

Gupta J, Dominic EA, Fink JC, Ojo AO, Barrows IR, Reilly MP, Townsend RR, Joffe MM, Rosas SE, Wolman M, Patel SS, Keane MG, Feldman HI, Kusek JW, Raj DS; CRIC Study Investigators.

PLoS One. 2015 Apr 24;10(4):e0124772. doi: 10.1371/journal.pone.0124772. eCollection 2015.

23.

Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease.

Gill K, Fink JC, Gilbertson DT, Monda KL, Muntner P, Lafayette RA, Petersen J, Chertow GM, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):654-62. doi: 10.1002/pds.3779. Epub 2015 Apr 22.

PMID:
25903095
24.

The Effect of Universal Glove and Gown Use on Adverse Events in Intensive Care Unit Patients.

Croft LD, Harris AD, Pineles L, Langenberg P, Shardell M, Fink JC, Simoni-Wastila L, Morgan DJ; Benefits of Universal Glove and Gown Primary Investigators.

Clin Infect Dis. 2015 Aug 15;61(4):545-53. doi: 10.1093/cid/civ315. Epub 2015 Apr 21.

PMID:
25900169
25.

Chronic pain and analgesic use in CKD: implications for patient safety.

Wu J, Ginsberg JS, Zhan M, Diamantidis CJ, Chen J, Woods C, Fink JC.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):435-42. doi: 10.2215/CJN.06520714. Epub 2015 Feb 20.

26.

Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, Dember LM, Fink JC, Frydrych A, Jensvold NG, Lustigova E, Nessel LC, Porter AC, Rahman M, Wright Nunes JA, Daviglus ML, Lash JP; CRIC Study Investigators.

Am J Kidney Dis. 2015 Mar;65(3):412-24. doi: 10.1053/j.ajkd.2014.09.016. Epub 2014 Nov 20.

27.

Retinopathy and progression of CKD: The CRIC study.

Grunwald JE, Pistilli M, Ying GS, Daniel E, Maguire MG, Xie D, Whittock-Martin R, Parker Ostroff C, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman HI, Kusek JW; Chronic Renal Insufficiency Cohort Study Investigators.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1217-24. doi: 10.2215/CJN.11761113. Epub 2014 May 8.

28.

Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.

Weir MR, Fink JC.

Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13. doi: 10.1097/01.mnh.0000444912.40418.45. Review.

PMID:
24670404
29.

Patient-reported and actionable safety events in CKD.

Ginsberg JS, Zhan M, Diamantidis CJ, Woods C, Chen J, Fink JC.

J Am Soc Nephrol. 2014 Jul;25(7):1564-73. doi: 10.1681/ASN.2013090921. Epub 2014 Feb 20.

31.

Directed use of the internet for health information by patients with chronic kidney disease: prospective cohort study.

Diamantidis CJ, Fink W, Yang S, Zuckerman MR, Ginsberg J, Hu P, Xiao Y, Fink JC.

J Med Internet Res. 2013 Nov 15;15(11):e251. doi: 10.2196/jmir.2848.

32.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

33.

Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.

34.

Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.

Hartley IR, Ginsberg JS, Diamantidis CJ, Zhan M, Walker L, Rattinger GB, Fink JC.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2123-31. doi: 10.2215/CJN.12671212. Epub 2013 Sep 19.

35.

Red blood cell transfusion use in patients with chronic kidney disease.

Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD.

Nephrol Dial Transplant. 2013 Jun;28(6):1504-15. doi: 10.1093/ndt/gfs580. Epub 2013 Feb 6.

PMID:
23389999
36.

Telenephrology: a novel approach to improve coordinated and collaborative care for chronic kidney disease.

Gordon EJ, Fink JC, Fischer MJ.

Nephrol Dial Transplant. 2013 Apr;28(4):972-81. doi: 10.1093/ndt/gfs552. Epub 2012 Dec 14.

PMID:
23243040
37.

Usability testing and acceptance of an electronic medication inquiry system for CKD patients.

Diamantidis CJ, Zuckerman M, Fink W, Aggarwal S, Prakash D, Fink JC.

Am J Kidney Dis. 2013 Apr;61(4):644-6. doi: 10.1053/j.ajkd.2012.09.016. Epub 2012 Nov 14. No abstract available.

PMID:
23157933
38.

Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort study.

Weir MR, Townsend RR, Fink JC, Teal V, Sozio SM, Anderson CA, Appel LJ, Turban S, Chen J, He J, Litbarg N, Ojo A, Rahman M, Rosen L, Steigerwalt S, Strauss L, Joffe MM.

Am J Nephrol. 2012;36(5):397-404. doi: 10.1159/000342966. Epub 2012 Oct 12.

39.

Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology.

Williams AW, Dwyer AC, Eddy AA, Fink JC, Jaber BL, Linas SL, Michael B, O'Hare AM, Schaefer HM, Shaffer RN, Trachtman H, Weiner DE, Falk AR; American Society of Nephrology Quality, and Patient Safety Task Force.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1664-72. doi: 10.2215/CJN.04970512. Epub 2012 Sep 13.

40.

Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study.

Grunwald JE, Alexander J, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker C, McWilliams K, Lo JC, Go A, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D, Jaar BG; CRIC Study Group.

Arch Ophthalmol. 2012 Sep;130(9):1136-44.

41.

Usability of a CKD educational website targeted to patients and their family members.

Diamantidis CJ, Zuckerman M, Fink W, Hu P, Yang S, Fink JC.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1553-60. doi: 10.2215/CJN.03690412. Epub 2012 Jul 12.

42.

Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.

Patel K, Diamantidis C, Zhan M, Hsu VD, Walker LD, Gardner J, Weir MR, Fink JC.

Am J Nephrol. 2012;36(1):19-26. doi: 10.1159/000339439. Epub 2012 Jun 13.

43.

Vascular access hemorrhages contribute to deaths among hemodialysis patients.

Ellingson KD, Palekar RS, Lucero CA, Kurkjian KM, Chai SJ, Schlossberg DS, Vincenti DM, Fink JC, Davies-Cole JO, Magri JM, Arduino MJ, Patel PR.

Kidney Int. 2012 Sep;82(6):686-92. doi: 10.1038/ki.2012.185. Epub 2012 Jun 13.

44.

Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).

Grunwald JE, Ying GS, Maguire M, Pistilli M, Daniel E, Alexander J, Whittock-Martin R, Parker C, Mohler E, Lo JC, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D, Coleman M, Keane MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

Am J Cardiol. 2012 Jul 15;110(2):246-53. doi: 10.1016/j.amjcard.2012.03.014. Epub 2012 Apr 18.

45.

A varying patient safety profile between black and nonblack adults with decreased estimated GFR.

Diamantidis CJ, Seliger SL, Zhan M, Walker L, Rattinger GB, Hsu VD, Fink JC.

Am J Kidney Dis. 2012 Jul;60(1):47-53. doi: 10.1053/j.ajkd.2012.01.023. Epub 2012 Apr 6.

PMID:
22483674
46.

Finding a common language for patient safety in CKD.

Fink JC, Joy MS, St Peter WL, Wahba IM; ASN Chronic Kidney Disease Advisory Group.

Clin J Am Soc Nephrol. 2012 Apr;7(4):689-95. doi: 10.2215/CJN.12781211. Epub 2012 Mar 8. Review.

47.

Genotype-based changes in serum uric acid affect blood pressure.

Parsa A, Brown E, Weir MR, Fink JC, Shuldiner AR, Mitchell BD, McArdle PF.

Kidney Int. 2012 Mar;81(5):502-7. doi: 10.1038/ki.2011.414. Epub 2011 Dec 21.

48.

Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.

Semba RD, Fink JC, Sun K, Cappola AR, Dalal M, Crasto C, Ferrucci L, Fried LP.

Clin J Am Soc Nephrol. 2012 Jan;7(1):85-91. doi: 10.2215/CJN.08070811. Epub 2011 Nov 10.

49.

Hemodynamic correlates of proteinuria in chronic kidney disease.

Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, Chen J, He J, Litbarg N, Ojo A, Rahman M, Rosen L, Sozio SM, Steigerwalt S, Strauss L, Joffe MM.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2403-10. doi: 10.2215/CJN.01670211. Epub 2011 Aug 18.

50.

Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A, Rader DJ, Reilly MP, Teal V, Teff K, Wright JT, Xie D.

Am J Nephrol. 2011;33(6):477-84. doi: 10.1159/000327618. Epub 2011 Apr 27. Erratum in: Am J Nephrol. 2012;35(2):208.

Supplemental Content

Support Center